亚洲国产成人久久77-亚洲国产成人久久99精品-亚洲国产成人久久精品hezyo-亚洲国产成人久久精品动漫-人妖hd-人妖ts在线,一本道高清DVD在线视频,2020亚洲永久精品导航,国产久久视频在线视频观看

當(dāng)前位置: 首頁 JCRQ2 期刊介紹(非官網(wǎng))
Current Gene Therapy

Current Gene TherapySCIE

國際簡稱:CURR GENE THER  參考譯名:當(dāng)前的基因治療

  • 中科院分區(qū)

    4區(qū)

  • CiteScore分區(qū)

    Q2

  • JCR分區(qū)

    Q2

基本信息:
ISSN:1566-5232
E-ISSN:1875-5631
是否OA:未開放
是否預(yù)警:否
TOP期刊:否
出版信息:
出版地區(qū):NETHERLANDS
出版商:Bentham Science Publishers B.V.
出版語言:English
出版周期:Quarterly
出版年份:2001
研究方向:醫(yī)學(xué)-遺傳學(xué)
評(píng)價(jià)信息:
影響因子:3.8
H-index:65
CiteScore指數(shù):6.7
SJR指數(shù):0.674
SNIP指數(shù):0.597
發(fā)文數(shù)據(jù):
Gold OA文章占比:5.88%
研究類文章占比:41.94%
年發(fā)文量:31
自引率:0.0277...
開源占比:0.036
出版撤稿占比:0
出版國人文章占比:0.4
OA被引用占比:0
英文簡介 期刊介紹 CiteScore數(shù)據(jù) 中科院SCI分區(qū) JCR分區(qū) 發(fā)文數(shù)據(jù) 常見問題

英文簡介Current Gene Therapy期刊介紹

Current Gene Therapy is a bi-monthly peer-reviewed journal aimed at academic and industrial scientists with an interest in major topics concerning basic research and clinical applications of gene and cell therapy of diseases. Cell therapy manuscripts can also include application in diseases when cells have been genetically modified. Current Gene Therapy publishes full-length/mini reviews and original research on the latest developments in gene transfer and gene expression analysis, vector development, cellular genetic engineering, animal models and human clinical applications of gene and cell therapy for the treatment of diseases.

Current Gene Therapy publishes reviews and original research containing experimental data on gene and cell therapy. The journal also includes manuscripts on technological advances, ethical and regulatory considerations of gene and cell therapy. Reviews should provide the reader with a comprehensive assessment of any area of experimental biology applied to molecular medicine that is not only of significance within a particular field of gene therapy and cell therapy but also of interest to investigators in other fields. Authors are encouraged to provide their own assessment and vision for future advances. Reviews are also welcome on late breaking discoveries on which substantial literature has not yet been amassed. Such reviews provide a forum for sharply focused topics of recent experimental investigations in gene therapy primarily to make these results accessible to both clinical and basic researchers. Manuscripts containing experimental data should be original data, not previously published.

期刊簡介Current Gene Therapy期刊介紹

《Current Gene Therapy》自2001出版以來,是一本醫(yī)學(xué)優(yōu)秀雜志。致力于發(fā)表原創(chuàng)科學(xué)研究結(jié)果,并為醫(yī)學(xué)各個(gè)領(lǐng)域的原創(chuàng)研究提供一個(gè)展示平臺(tái),以促進(jìn)醫(yī)學(xué)領(lǐng)域的的進(jìn)步。該刊鼓勵(lì)先進(jìn)的、清晰的闡述,從廣泛的視角提供當(dāng)前感興趣的研究主題的新見解,或?qū)彶槎嗄陙砟硞€(gè)重要領(lǐng)域的所有重要發(fā)展。該期刊特色在于及時(shí)報(bào)道醫(yī)學(xué)領(lǐng)域的最新進(jìn)展和新發(fā)現(xiàn)新突破等。該刊近一年未被列入預(yù)警期刊名單,目前已被權(quán)威數(shù)據(jù)庫SCIE收錄,得到了廣泛的認(rèn)可。

該期刊投稿重要關(guān)注點(diǎn):

Cite Score數(shù)據(jù)(2024年最新版)Current Gene Therapy Cite Score數(shù)據(jù)

  • CiteScore:6.7
  • SJR:0.674
  • SNIP:0.597
學(xué)科類別 分區(qū) 排名 百分位
大類:Medicine 小類:Genetics (clinical) Q2 28 / 99

72%

大類:Medicine 小類:Genetics Q2 107 / 347

69%

大類:Medicine 小類:Drug Discovery Q2 54 / 157

65%

大類:Medicine 小類:Molecular Medicine Q2 71 / 178

60%

大類:Medicine 小類:Molecular Biology Q2 175 / 410

57%

CiteScore 是由Elsevier(愛思唯爾)推出的另一種評(píng)價(jià)期刊影響力的文獻(xiàn)計(jì)量指標(biāo)。反映出一家期刊近期發(fā)表論文的年篇均引用次數(shù)。CiteScore以Scopus數(shù)據(jù)庫中收集的引文為基礎(chǔ),針對(duì)的是前四年發(fā)表的論文的引文。CiteScore的意義在于,它可以為學(xué)術(shù)界提供一種新的、更全面、更客觀地評(píng)價(jià)期刊影響力的方法,而不僅僅是通過影響因子(IF)這一單一指標(biāo)來評(píng)價(jià)。

歷年Cite Score趨勢圖

中科院SCI分區(qū)Current Gene Therapy 中科院分區(qū)

中科院 2023年12月升級(jí)版 綜述期刊:是 Top期刊:否
大類學(xué)科 分區(qū) 小類學(xué)科 分區(qū)
醫(yī)學(xué) 4區(qū) GENETICS & HEREDITY 遺傳學(xué) 4區(qū)

中科院分區(qū)表 是以客觀數(shù)據(jù)為基礎(chǔ),運(yùn)用科學(xué)計(jì)量學(xué)方法對(duì)國際、國內(nèi)學(xué)術(shù)期刊依據(jù)影響力進(jìn)行等級(jí)劃分的期刊評(píng)價(jià)標(biāo)準(zhǔn)。它為我國科研、教育機(jī)構(gòu)的管理人員、科研工作者提供了一份評(píng)價(jià)國際學(xué)術(shù)期刊影響力的參考數(shù)據(jù),得到了全國各地高校、科研機(jī)構(gòu)的廣泛認(rèn)可。

中科院分區(qū)表 將所有期刊按照一定指標(biāo)劃分為1區(qū)、2區(qū)、3區(qū)、4區(qū)四個(gè)層次,類似于“優(yōu)、良、及格”等。最開始,這個(gè)分區(qū)只是為了方便圖書管理及圖書情報(bào)領(lǐng)域的研究和期刊評(píng)估。之后中科院分區(qū)逐步發(fā)展成為了一種評(píng)價(jià)學(xué)術(shù)期刊質(zhì)量的重要工具。

歷年中科院分區(qū)趨勢圖

JCR分區(qū)Current Gene Therapy JCR分區(qū)

2023-2024 年最新版
按JIF指標(biāo)學(xué)科分區(qū) 收錄子集 分區(qū) 排名 百分位
學(xué)科:GENETICS & HEREDITY SCIE Q2 49 / 191

74.6%

按JCI指標(biāo)學(xué)科分區(qū) 收錄子集 分區(qū) 排名 百分位
學(xué)科:GENETICS & HEREDITY SCIE Q2 65 / 191

66.23%

JCR分區(qū)的優(yōu)勢在于它可以幫助讀者對(duì)學(xué)術(shù)文獻(xiàn)質(zhì)量進(jìn)行評(píng)估。不同學(xué)科的文章引用量可能存在較大的差異,此時(shí)單獨(dú)依靠影響因子(IF)評(píng)價(jià)期刊的質(zhì)量可能是存在一定問題的。因此,JCR將期刊按照學(xué)科門類和影響因子分為不同的分區(qū),這樣讀者可以根據(jù)自己的研究領(lǐng)域和需求選擇合適的期刊。

歷年影響因子趨勢圖

發(fā)文數(shù)據(jù)

2023-2024 年國家/地區(qū)發(fā)文量統(tǒng)計(jì)
  • 國家/地區(qū)數(shù)量
  • CHINA MAINLAND58
  • USA17
  • India13
  • Iran8
  • Saudi Arabia7
  • Italy6
  • Japan5
  • Bangladesh4
  • Argentina3
  • Australia2

本刊中國學(xué)者近年發(fā)表論文

  • 1、Novel Combination Oncolytic Adenoviral Gene Therapy Armed with Dm-dNK and CD40L for Breast Cancer.

    Author: Wang Q1, Yang M1, Zhang Y2, Zhong L3, Zheng X1.

    Journal: Curr Gene Ther. 2019 Mar 6. doi: 10.2174/1566523219666190307094713. [Epub ahead of print]

  • 2、Gene Therapy on the Road

    Author: Feng YM1.

    Journal: Curr Gene Ther. 2019 May 10. doi: 10.2174/1566523219999190426144513. [Epub ahead of print]

  • 3、Novel p53 delivery systems in the treatment of head and neck cancer.

    Author: Lu Y1, Wang H1.

    Journal: Curr Gene Ther. 2019 May 10. doi: 10.2174/1566523219666190510120236. [Epub ahead of print]

  • 4、Advances in liver-directed gene therapy for hepatocellular carcinoma by non-viral delivery systems.

    Author: Ding B, Li T, Zhang J, Zhao L, Zhai G.

    Journal: Curr Gene Ther. 2012 Apr 1;12(2):92-102.

  • 5、Biodistribution and safety assessment of bladder cancer specific recombinant oncolytic adenovirus in subcutaneous xenografts tumor model in nude mice.

    Author: Wang F, Wang Z, Tian H, Qi M, Zhai Z, Li S, Li R, Zhang H, Wang W, Fu S, Lu J, Rodriguez R, Guo Y, Zhou L.

    Journal: Curr Gene Ther. 2012 Apr 1;12(2):67-76.

  • 6、Current advances in vehicles for brain gene delivery.

    Author: Zhang X, Zhao L, Wu J, Dong H, Xu F, Gong G, Hu Y.

    Journal: Curr Gene Ther. 2012 Oct;12(5):423-36.

  • 7、MicroRNAs and the Warburg Effect: new players in an old arena.

    Author: Gao P, Sun L, He X, Cao Y, Zhang H.

    Journal: Curr Gene Ther. 2012 Aug;12(4):285-91.

  • 8、Equipping CAR-modified T cells with a brake to prevent chronic adverse effects.

    Author: Wang W, Wang Y.

    Journal: Curr Gene Ther. 2012 Dec;12(6):493-5.

投稿常見問題

通訊方式:BENTHAM SCIENCE PUBL LTD, EXECUTIVE STE Y26, PO BOX 7917, SAIF ZONE, SHARJAH, U ARAB EMIRATES, 1200 BR。